459 related articles for article (PubMed ID: 6657667)
1. Study of inhibitor and nucleator activities in calcium stone formers.
Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of factors involved in calcium stone formation.
Abraham PA; Smith CL
Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
[TBL] [Abstract][Full Text] [Related]
3. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
4. Seasonal variations in urinary risk factors among patients with nephrolithiasis.
Stuart RO 2nd ; Hill K; Poindexter J; Pak CY
J Lithotr Stone Dis; 1991 Jan; 3(1):18-27. PubMed ID: 11536932
[TBL] [Abstract][Full Text] [Related]
5. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
[TBL] [Abstract][Full Text] [Related]
6. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
Lagemann M; Anders D; Graef V; Bödeker RH
Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
[TBL] [Abstract][Full Text] [Related]
7. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers.
Sriboonlue P; Prasongwattana V; Tungsanga K; Sitprija V
J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
Murayama T; Taguchi H
Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
[TBL] [Abstract][Full Text] [Related]
9. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
[TBL] [Abstract][Full Text] [Related]
10. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
Takasaki E
Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
[TBL] [Abstract][Full Text] [Related]
11. Changes in urinary composition of calcium oxalate stone formers.
Rahman B; Rahman MA
Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
Wilson DR; Pylypchuk G; Ehrig U
Can Med Assoc J; 1979 Mar; 120(6):666-9. PubMed ID: 436048
[TBL] [Abstract][Full Text] [Related]
13. Circadian variations of blood and urinary constituents in renal stone formers.
Singh RK; Bansal A; Bansal SK; Rai SP
Prog Clin Biol Res; 1990; 341B():551-7. PubMed ID: 2217342
[No Abstract] [Full Text] [Related]
14. An evaluation of the physicochemical risk for renal stone disease during pregnancy.
Smith CL; Kristensen C; Davis M; Abraham PA
Clin Nephrol; 2001 Mar; 55(3):205-11. PubMed ID: 11316240
[TBL] [Abstract][Full Text] [Related]
15. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
16. Effect of prolonged bedrest on the propensity for renal stone formation.
Hwang TI; Hill K; Schneider V; Pak CY
J Clin Endocrinol Metab; 1988 Jan; 66(1):109-12. PubMed ID: 3335600
[TBL] [Abstract][Full Text] [Related]
17. [Studies of urinary risk factors in urolithiasis].
Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
[TBL] [Abstract][Full Text] [Related]
18. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.
Pylypchuk G; Ehrig U; Wilson DR
Can Med Assoc J; 1979 Mar; 120(6):658-65. PubMed ID: 436047
[TBL] [Abstract][Full Text] [Related]
20. Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate.
Subha K; Varalakshmi P
Biochem Mol Biol Int; 1993 Feb; 29(2):271-80. PubMed ID: 7684293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
